The SRC family kinase inhibitor NXP900 demonstrates potent antitumor activity in squamous cell carcinomas von Dash, Sweta, Hanson, Sabrina, King, Ben, Nyswaner, Katherine, Foss, Kelcie, Tesi, Noelle, Harvey, Mungo J.B., Navarro-Marchal, Saúl A., Woods, Allison, Poradosu, Enrique, Unciti-Broceta, Asier, Carragher, Neil O., Brognard, John

Volltext